573.48 USD
-0.75 (-0.13%)
572.99 USD
-0.49 (-0.09%)
Overall ISRG gets a fundamental rating of 7 out of 10. We evaluated ISRG against 188 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making ISRG a very profitable company, without any liquidiy or solvency issues. ISRG is growing strongly while it is still valued neutral. This is a good combination! This makes ISRG very considerable for growth and quality investing!
1. Profitability
1.1 Basic Checks
ISRG had positive earnings in the past year.
In the past year ISRG had a positive cash flow from operations.
ISRG had positive earnings in each of the past 5 years.
Each year in the past 5 years ISRG had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 14.19%, ISRG belongs to the top of the industry, outperforming 95.74% of the companies in the same industry.
Looking at the Return On Equity, with a value of 16.12%, ISRG belongs to the top of the industry, outperforming 90.96% of the companies in the same industry.
ISRG has a Return On Invested Capital of 14.96%. This is amongst the best in the industry. ISRG outperforms 95.21% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ISRG is above the industry average of 8.72%.
The 3 year average ROIC (12.20%) for ISRG is below the current ROIC(14.96%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.19% | ||
| ROE | 16.12% | ||
| ROIC | 14.96% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.21%
ROE(5y)12.97%
ROIC(3y)12.2%
ROIC(5y)11.86%
1.3 Margins
Looking at the Profit Margin, with a value of 28.58%, ISRG belongs to the top of the industry, outperforming 96.28% of the companies in the same industry.
ISRG's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 29.44%, ISRG belongs to the top of the industry, outperforming 97.34% of the companies in the same industry.
In the last couple of years the Operating Margin of ISRG has declined.
The Gross Margin of ISRG (66.38%) is better than 69.15% of its industry peers.
ISRG's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 29.44% | ||
| PM (TTM) | 28.58% | ||
| GM | 66.38% |
OM growth 3Y-4.19%
OM growth 5Y-1.68%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ISRG is creating some value.
Compared to 1 year ago, ISRG has more shares outstanding
Compared to 5 years ago, ISRG has more shares outstanding
ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
There is no outstanding debt for ISRG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | N/A |
ROIC/WACC1.73
WACC8.66%
2.3 Liquidity
A Current Ratio of 4.97 indicates that ISRG has no problem at all paying its short term obligations.
The Current ratio of ISRG (4.97) is better than 77.66% of its industry peers.
ISRG has a Quick Ratio of 4.20. This indicates that ISRG is financially healthy and has no problem in meeting its short term obligations.
ISRG has a Quick ratio of 4.20. This is in the better half of the industry: ISRG outperforms 78.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.97 | ||
| Quick Ratio | 4.2 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 28.12% over the past year.
ISRG shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.48% yearly.
ISRG shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.18%.
Measured over the past years, ISRG shows a quite strong growth in Revenue. The Revenue has been growing by 13.27% on average per year.
EPS 1Y (TTM)28.12%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%30.43%
Revenue 1Y (TTM)22.18%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%22.91%
3.2 Future
ISRG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.47% yearly.
ISRG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.12% yearly.
EPS Next Y19.93%
EPS Next 2Y16.17%
EPS Next 3Y15.85%
EPS Next 5Y15.47%
Revenue Next Year21.17%
Revenue Next 2Y18.1%
Revenue Next 3Y16.53%
Revenue Next 5Y14.12%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 66.61, ISRG can be considered very expensive at the moment.
ISRG's Price/Earnings ratio is a bit cheaper when compared to the industry. ISRG is cheaper than 67.02% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.31. ISRG is valued rather expensively when compared to this.
Based on the Price/Forward Earnings ratio of 57.97, the valuation of ISRG can be described as expensive.
ISRG's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ISRG is cheaper than 67.02% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.56, ISRG is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 66.61 | ||
| Fwd PE | 57.97 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ISRG is valued a bit cheaper than 66.49% of the companies in the same industry.
ISRG's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ISRG is cheaper than 69.68% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 89.51 | ||
| EV/EBITDA | 56.5 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
ISRG has an outstanding profitability rating, which may justify a higher PE ratio.
ISRG's earnings are expected to grow with 15.85% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.34
PEG (5Y)5.8
EPS Next 2Y16.17%
EPS Next 3Y15.85%
5. Dividend
5.1 Amount
No dividends for ISRG!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
573.48
-0.75 (-0.13%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners88.66%
Inst Owner Change3.06%
Ins Owners0.45%
Ins Owner Change0.58%
Market Cap203.30B
Revenue(TTM)9.61B
Net Income(TTM)2.75B
Analysts78.54
Price Target610.08 (6.38%)
Short Float %1.92%
Short Ratio2.8
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.16%
Min EPS beat(2)11.61%
Max EPS beat(2)18.71%
EPS beat(4)4
Avg EPS beat(4)13.53%
Min EPS beat(4)3.05%
Max EPS beat(4)20.76%
EPS beat(8)8
Avg EPS beat(8)11%
EPS beat(12)11
Avg EPS beat(12)7.6%
EPS beat(16)13
Avg EPS beat(16)5.75%
Revenue beat(2)2
Avg Revenue beat(2)2%
Min Revenue beat(2)1.84%
Max Revenue beat(2)2.17%
Revenue beat(4)4
Avg Revenue beat(4)2.55%
Min Revenue beat(4)1.09%
Max Revenue beat(4)5.12%
Revenue beat(8)5
Avg Revenue beat(8)1.17%
Revenue beat(12)6
Avg Revenue beat(12)0.55%
Revenue beat(16)8
Avg Revenue beat(16)0.31%
PT rev (1m)0.23%
PT rev (3m)1.86%
EPS NQ rev (1m)0.25%
EPS NQ rev (3m)3.25%
EPS NY rev (1m)5.67%
EPS NY rev (3m)5.61%
Revenue NQ rev (1m)-0.07%
Revenue NQ rev (3m)1.69%
Revenue NY rev (1m)1.24%
Revenue NY rev (3m)1.21%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 66.61 | ||
| Fwd PE | 57.97 | ||
| P/S | 21.15 | ||
| P/FCF | 89.51 | ||
| P/OCF | 68.67 | ||
| P/B | 11.93 | ||
| P/tB | 12.18 | ||
| EV/EBITDA | 56.5 |
EPS(TTM)8.61
EY1.5%
EPS(NY)9.89
Fwd EY1.72%
FCF(TTM)6.41
FCFY1.12%
OCF(TTM)8.35
OCFY1.46%
SpS27.11
BVpS48.07
TBVpS47.09
PEG (NY)3.34
PEG (5Y)5.8
Graham Number96.5
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.19% | ||
| ROE | 16.12% | ||
| ROCE | 16.61% | ||
| ROIC | 14.96% | ||
| ROICexc | 29.62% | ||
| ROICexgc | 30.86% | ||
| OM | 29.44% | ||
| PM (TTM) | 28.58% | ||
| GM | 66.38% | ||
| FCFM | 23.63% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.21%
ROE(5y)12.97%
ROIC(3y)12.2%
ROIC(5y)11.86%
ROICexc(3y)18.44%
ROICexc(5y)19.03%
ROICexgc(3y)19.29%
ROICexgc(5y)20.12%
ROCE(3y)13.54%
ROCE(5y)13.16%
ROICexgc growth 3Y-7.59%
ROICexgc growth 5Y-7%
ROICexc growth 3Y-6.87%
ROICexc growth 5Y-6.06%
OM growth 3Y-4.19%
OM growth 5Y-1.68%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
F-Score8
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 111.36% | ||
| Cap/Sales | 7.17% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 85.84% | ||
| Profit Quality | 82.69% | ||
| Current Ratio | 4.97 | ||
| Quick Ratio | 4.2 | ||
| Altman-Z | N/A |
F-Score8
WACC8.66%
ROIC/WACC1.73
Cap/Depr(3y)197.35%
Cap/Depr(5y)162.98%
Cap/Sales(3y)12.27%
Cap/Sales(5y)10.16%
Profit Quality(3y)56.77%
Profit Quality(5y)75.99%
High Growth Momentum
Growth
EPS 1Y (TTM)28.12%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%30.43%
EPS Next Y19.93%
EPS Next 2Y16.17%
EPS Next 3Y15.85%
EPS Next 5Y15.47%
Revenue 1Y (TTM)22.18%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%22.91%
Revenue Next Year21.17%
Revenue Next 2Y18.1%
Revenue Next 3Y16.53%
Revenue Next 5Y14.12%
EBIT growth 1Y36.82%
EBIT growth 3Y8.76%
EBIT growth 5Y11.37%
EBIT Next Year40.01%
EBIT Next 3Y23.66%
EBIT Next 5Y20.46%
FCF growth 1Y80.69%
FCF growth 3Y-9.1%
FCF growth 5Y2.14%
OCF growth 1Y46.32%
OCF growth 3Y4.95%
OCF growth 5Y8.61%
INTUITIVE SURGICAL INC / ISRG FAQ
Can you provide the ChartMill fundamental rating for INTUITIVE SURGICAL INC?
ChartMill assigns a fundamental rating of 7 / 10 to ISRG.
Can you provide the valuation status for INTUITIVE SURGICAL INC?
ChartMill assigns a valuation rating of 4 / 10 to INTUITIVE SURGICAL INC (ISRG). This can be considered as Fairly Valued.
How profitable is INTUITIVE SURGICAL INC (ISRG) stock?
INTUITIVE SURGICAL INC (ISRG) has a profitability rating of 8 / 10.
What is the financial health of INTUITIVE SURGICAL INC (ISRG) stock?
The financial health rating of INTUITIVE SURGICAL INC (ISRG) is 7 / 10.